Ramm Pharma (RAMM) Stock Statistics & Valuation Metrics

Ramm Pharma has a market cap or net worth of C$4.18M. The enterprise value is C$3.08M.

Ramm Pharma has 119,389,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ramm Pharma’s return on equity (ROE) is -1.21 and return on invested capital (ROIC) is -48.90%.

The current PE Ratio of Ramm Pharma is ―. Ramm Pharma’s PEG ratio is -0.00061.

In the last 12 months, Ramm Pharma had revenue of 4.34M and earned -16.50M in profits. Earnings per share was -0.14.

In the last 12 months, operating cash flow was -1.58M and capital expenditures -21.90K, giving a free cash flow of -1.61M billion.

Ramm Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Ramm Pharma upcoming earnings date is Feb 26, 2026, Before Open (Confirmed).

Ramm Pharma as a current ratio of 1.77, with Debt / Equity ratio of 0.22%

In the past 12 months, Ramm Pharma has paid 8.12K in taxes.

Ramm Pharma EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.14.

Ramm Pharma has C$529.41K in cash and marketable securities with C$27.79K in debt, giving a net cash position of C$501.62K billion.

Gross margin is 23.64%, with operating margin of -155.68%, and net profit margin of -380.06%.

The average price target for Ramm Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―